Schedule 13D ownership disclosure
TRINITY BIOTECH INVT LTD
Class A Ordinary Shares, $0.0109 par value per share · CUSIP: 896438504
Event date: 2025-03-21
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Perceptive Advisors LLCReported CIK 0001224962
Shares: 85,800,000 · Class: 19.8%
- Perceptive Credit Advisors LLCReported CIK 0001877081
Shares: 85,800,000 · Class: 19.8%
- Joseph EdelmanReported CIK 0001164426
Shares: 85,800,000 · Class: 19.8%
- Perceptive Credit Holdings II, L.P.
Shares: 45,800,000 · Class: 10.6%
- Perceptive Credit Holdings III, L.P.Reported CIK 0001877078
Shares: 40,000,000 · Class: 9.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-044627
- Form type
- SCHEDULE 13D/A
- Filer
- PERCEPTIVE ADVISORS LLC
- CIK
- CIK 1224962
- Filed
- Mar 25, 2025
- Reporting period
- Mar 21, 2025
- Description
- Schedule 13D beneficial ownership